Zim Labs Q3 FY26: 9M PAT Falls 71% YoY on Weak First Half

EBITDA margin compressionResults View source PDF Explain this filing

ZIMLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.6%Reaction day

₹77.00

prior close

₹79.80

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.5%-4.1% vs market

On the reaction day the stock moved 4.1 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-3.2

10m

-4.4

15m

-4.7

30m

-4.8

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

-4.6-0.5-4.1

Next day

-7.1-2.0-5.1

-7.0-2.7-4.3

-9.0-1.7-7.3

-7.1-1.4-5.6

-7.8-2.8-5.0

-8.9-2.8-6.1

15d

-13.1-8.4-4.7

-16.6-9.1-7.5

-5.8-4.0-1.8

+37.7+2.6+35.0

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

For Q3 FY26, consolidated revenue grew 12.8% YoY to Rs 10,865.93 lakhs and PAT rose 10% to Rs 439.76 lakhs, showing recovery. But 9M FY26 PAT fell 71% YoY to Rs 209.81 lakhs as Q1 had a loss of about Rs 187 lakhs. 9M revenue was nearly flat at Rs 26,912.67 lakhs. Standalone results similar. Margins before interest, depreciation and tax fell from 12.3% to 10.4%. New auditor Deloitte Haskins and Sells replaced the prior auditor.

Likely market impact

Mixed - quarterly recovery positive but weak half-year performance and margin compression are concerns